We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00002939
First Posted: April 29, 2004
Last Update Posted: September 5, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Chicago
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2002
  Primary Completion Date: February 2001 (Final data collection date for primary outcome measure)